Price T Rowe Associates Inc Annexon, Inc. Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,104,385 shares of ANNX stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,104,385

Previous 1,034,652 6.74%

Holding current value

$2.69 Million

Previous $6.13 Million 7.49%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.44 - $7.63 $309,614 - $532,062	69,733 Added 6.74%	1,104,385 $5.67 Million
Q3 2024 Nov 14, 2024	SELL	$4.49 - $7.2 $268,591 - $430,704	-59,820 Reduced 5.47%	1,034,652 $6.13 Million
Q2 2024 Aug 14, 2024	SELL	$4.33 - $6.79 $992,574 - $1.56 Million	-229,232 Reduced 17.32%	1,094,472 $5.36 Million
Q1 2024 May 15, 2024	BUY	$4.03 - $7.81 $5.28 Million - $10.2 Million	1,311,195 Added 10482.01%	1,323,704 $9.49 Million
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $20,389 - $57,916	12,509 New	12,509 $57,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $4.06 $2.8 Million - $5.38 Million	-1,324,733 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.73 - $11.94 $4.24 Million - $18.5 Million	-1,551,934 Reduced 53.95%	1,324,733 $3.62 Million
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $13.2 Million - $25.3 Million	1,151,996 Added 66.8%	2,876,667 $33.1 Million
Q3 2021 Nov 15, 2021	BUY	$16.35 - $23.4 $6.77 Million - $9.69 Million	414,187 Added 31.61%	1,724,671 $32.1 Million
Q2 2021 Aug 16, 2021	SELL	$17.81 - $27.48 $514,299 - $793,539	-28,877 Reduced 2.16%	1,310,484 $29.5 Million
Q1 2021 May 17, 2021	BUY	$22.0 - $35.01 $2.94 Million - $4.69 Million	133,858 Added 11.1%	1,339,361 $37.3 Million
Q4 2020 Feb 16, 2021	BUY	$20.81 - $30.55 $25.1 Million - $36.8 Million	1,205,503 New	1,205,503 $30.2 Million

Others Institutions Holding ANNX

# of Institutions

156

Shares Held

98.2M

Call Options Held

146K

Put Options Held

174K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $116M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Annexon, Inc. Transaction History